About NextGen Biomed

The discovery and development of innovative biologic therapies, along with the optimization of therapeutic development processes, are increasingly recognized as top priorities in the life sciences industry. R&D leaders must ensure that innovative biologics are strategically integrated into the pipeline, supported by the latest technologies & research platforms, early-stage investments, scalable & sustainable manufacturing strategies and a streamlined regulatory path to accelerate their journey from the lab to the patient.

NextGen Biomed is the platform to advance the fields of biologics, vaccines & novel therapeutics approaches, helping to deliver life-saving medicines to patients faster.

NextGen Biomed People Icon

We are committed to creating the bridge for interdisciplinary communication through expertly curated sessions and strategic discussions

NextGen Biomed Book Icon
We bring you the latest scientific breakthroughs and opportunities to benchmark your work across diverse modalities, helping you refine and optimize your therapeutic strategies
NextGen Biomed MicroscopeIcon
We introduce you to a range of cutting-edge technologies and research solutions that you can integrate into your drug discovery and development workflow

Unlocking the Complexities of Next Generation Biomedicines

NextGen Biomed covers the latest R&D trends in proteins & antibodies, peptides and oligonucleotides and their therapeutic applications alongside cutting-edge developments in immunotherapies, cell & gene therapies and vaccine development. As these therapeutic modalities evolve and development challenges become more complex, there is an increasing need for a more nuanced understanding of their mechanisms, optimisation strategies, and scalability to drive improved outcomes.

We unite R&D groups in a collaborative environment that fosters partnerships and strengthens interdisciplinary connections across diverse teams.

Old Brands to New Brand Image (Arrows)
NextGen Biomed Brand at a Glance

Download the Brand at a Glance

Uniting biopharma, research and healthcare experts from around the globe through in-person and digital touchpoints